Replication Study for the Association of Five SNPs Identified by GWAS and Trastuzumab-Induced Cardiotoxicity in Japanese and Singaporean Cohorts-Reference-Cited by-同舟云学术

Replication Study for the Association of Five SNPs Identified by GWAS and Trastuzumab-Induced Cardiotoxicity in Japanese and Singaporean Cohorts

Published:2022-08-01 Issue:8 Volume:45 Page:1198-1202
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biological & Pharmaceutical Bulletin

Author:

Udagawa Chihiro¹,Kuah Sherwin²,Shimoi Tatsunori³,Kato Ken⁴,Yoshida Teruhiko¹,Nakano Mari Hara⁵,Shimo Arata⁵,Kojima Yasuyuki⁵,Yoshie Reiko⁵,Tsugawa Koichiro⁵,Mushiroda Taisei⁶,Tan Ern Yu²,Zembutsu Hitoshi⁷

Affiliation:

1. Department of Genetics Medicine and services, National Cancer Center Hospital

2. Department of General Surgery, Tan Tock Seng Hospital

3. Department of Medical Oncology, National Cancer Center Hospital

4. Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital

5. Division of Breast and Endocrine Surgery, Department of Surgery, St. Marianna University School of Medicine

6. Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Science

7. Department of Clinical Genomics, National Cancer Center Research Institute

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/45/8/45_b22-00136/_pdf

Reference25 articles.

1. 1) Hudis CA. Trastuzumab--mechanism of action and use in clinical practice. N. Engl. J. Med., 357, 39–51 (2007).

2. 2) Gennari R, Menard S, Fagnoni F, Ponchio L, Scelsi M, Tagliabue E, Castiglioni F, Villani L, Magalotti C, Gibelli N, Oliviero B, Ballardini B, Da Prada G, Zambelli A, Costa A. Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2. Clin. Cancer Res., 10, 5650–5655 (2004).

3. 3) Collins DM, O’Donovan N, McGowan PM, O’Sullivan F, Duffy MJ, Crown J. Trastuzumab induces antibody-dependent cell-mediated cytotoxicity (ADCC) in HER-2-non-amplified breast cancer cell lines. Ann. Oncol., 23, 1788–1795 (2012).

4. 4) Feldman AM, Lorell BH, Reis SE. Trastuzumab in the treatment of metastatic breast cancer: anticancer therapy versus cardiotoxicity. Circulation, 102, 272–274 (2000).

5. 5) Boku N. HER2-positive gastric cancer. Gastric Cancer, 17, 1–12 (2014).

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review;Cancers;2023-06-22

2. CARDIOVASCULAR COMPLICATIONS IN NON-SMALL CELL LUNG CANCER PATIENTS: CURRENT STATUS OF THE PROBLEM;"Medical & pharmaceutical journal "Pulse";2023-01-30